$KNW
KNOW LABS, INC. Stock $knw

$knw Overview Financials Valuation SEC Filings Company Website

2021 Q3 Form 10-Q Financial Statement

#000165495421009080 Filed on August 16, 2021

Income Statement

Concept	2021 Q3	2021 Q2	2020 Q2
Revenue	$0.00	$0.00	$0.00
YoY Change			-100.0%
Cost Of Revenue	$0.00	$0.00	$0.00
YoY Change			-100.0%
Gross Profit	$0.00	$0.00	$0.00
YoY Change			-100.0%
Gross Profit Margin
Selling, General & Admin	$1.542M	$994.2K	$634.2K
YoY Change	-6.43%	56.78%	-4.65%
% of Gross Profit
Research & Development	$875.9K	$868.6K	$375.2K
YoY Change	21.62%	131.47%	-15.01%
% of Gross Profit
Depreciation & Amortization	$34.72K	$64.98K	$51.01K
YoY Change	-56.0%	27.4%	113.32%
% of Gross Profit
Operating Expenses	$2.418M	$1.863M	$1.009M
YoY Change	1.3%	84.54%	-10.72%
Operating Profit	-$2.418M	-$1.863M	-$1.009M
YoY Change	1.3%	84.54%	-1.53%
Interest Expense	-$5.178M	$5.228M	$1.189M
YoY Change	169.06%	339.75%	-181.3%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$5.228M	-$1.896M
YoY Change	-100.0%	175.79%	-23133.71%
Pretax Income	-$7.596M	-$7.091M	-$2.905M
YoY Change	76.17%	144.08%	34.85%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$7.596M	-$7.091M	-$2.905M
YoY Change	76.17%	144.08%	34.85%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$220.0K	-$228.4K	-$122.5K
COMMON SHARES
Basic Shares Outstanding	34.43M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2021 Q3	2021 Q2	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.26M	$13.87M	$4.662M
YoY Change	185.2%	197.49%	73.41%
Cash & Equivalents	$12.26M	$13.87M	$4.662M
Short-Term Investments
Other Short-Term Assets			$0.00
YoY Change			-100.0%
Inventory			$0.00
Prepaid Expenses
Receivables	$0.00		$0.00
Other Receivables	$0.00		$0.00
Total Short-Term Assets	$12.26M	$13.87M	$4.662M
YoY Change	185.2%	197.49%	63.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$328.5K	$111.2K	$207.7K
YoY Change	155.31%	-46.45%	42.06%
Goodwill
YoY Change
Intangibles	$0.00	$0.00
YoY Change	-100.0%
Long-Term Investments
YoY Change
Other Assets	$13.77K	$13.77K	$25.18K
YoY Change	-45.31%	-45.31%	82.86%
Total Long-Term Assets	$631.3K	$155.6K	$377.4K
YoY Change	64.41%	-58.77%	-21.01%
TOTAL ASSETS
Total Short-Term Assets	$12.26M	$13.87M	$4.662M
Total Long-Term Assets	$631.3K	$155.6K	$377.4K
Total Assets	$12.89M	$14.03M	$5.040M
YoY Change	175.29%	178.3%	51.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$419.1K	$405.0K	$441.4K
YoY Change	-15.08%	-8.26%	-47.21%
Accrued Expenses	$893.1K	$585.8K	$951.7K
YoY Change	122.63%	-38.45%	6.28%
Deferred Revenue
YoY Change
Short-Term Debt	$9.191M	$5.007M	$2.405M
YoY Change	131.66%	108.16%	-4.26%
Long-Term Debt Due		$226.2K
YoY Change
Total Short-Term Liabilities	$11.04M	$7.820M	$3.798M
YoY Change	73.88%	105.9%	-10.5%
LONG-TERM LIABILITIES
Long-Term Debt	$431.8K	$205.6K	$0.00
YoY Change	90.92%
Other Long-Term Liabilities	$178.2K	$0.00	$825.0K
YoY Change	665.99%	-100.0%
Total Long-Term Liabilities	$610.0K	$205.6K	$825.0K
YoY Change	144.55%	-75.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.04M	$7.820M	$3.798M
Total Long-Term Liabilities	$610.0K	$205.6K	$825.0K
Total Liabilities	$11.65M	$8.026M	$4.623M
YoY Change	76.55%	73.6%	8.94%
SHAREHOLDERS EQUITY
Retained Earnings	-$81.33M	-$73.73M
YoY Change	45.31%
Common Stock	$35.17K	$33.72K
YoY Change	41.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.242M	$6.000M	$416.5K
YoY Change
Total Liabilities & Shareholders Equity	$12.89M	$14.03M	$5.040M
YoY Change	175.29%	178.3%	51.65%

Cashflow Statement

Concept	2021 Q3	2021 Q2	2020 Q2
OPERATING ACTIVITIES
Net Income	-$7.596M	-$7.091M	-$2.905M
YoY Change	76.17%	144.08%	34.85%
Depreciation, Depletion And Amortization	$34.72K	$64.98K	$51.01K
YoY Change	-56.0%	27.4%	113.32%
Cash From Operating Activities	-$1.706M	-$1.897M	-$977.8K
YoY Change	36.75%	94.03%	30.04%
INVESTING ACTIVITIES
Capital Expenditures	-$252.0K	-$12.58K	$14.68K
YoY Change	341.53%	-185.69%	-373.37%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$252.0K	-$12.58K	$14.68K
YoY Change	341.53%	-185.69%	-373.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	346.2K	83.34K	4.849M
YoY Change	-63.19%	-98.28%	1162.39%
NET CHANGE
Cash From Operating Activities	-1.706M	-1.897M	-977.8K
Cash From Investing Activities	-252.0K	-12.58K	14.68K
Cash From Financing Activities	346.2K	83.34K	4.849M
Net Change In Cash	-1.612M	-1.826M	3.886M
YoY Change	342.63%	-147.0%	-1141.19%
FREE CASH FLOW
Cash From Operating Activities	-$1.706M	-$1.897M	-$977.8K
Capital Expenditures	-$252.0K	-$12.58K	$14.68K
Free Cash Flow	-$1.454M	-$1.885M	-$992.5K
YoY Change	22.14%	89.89%	32.94%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	34433955	shares
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13870183	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4298179	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	13870183	USD
CY2020Q3	us-gaap	Assets Current AssetsCurrent	4298179	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	111244	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	128671	USD
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	0	USD
CY2020Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	101114	USD
CY2021Q2	us-gaap	Other Assets OtherAssets	13767	USD
CY2020Q3	us-gaap	Other Assets OtherAssets	25180	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	30581	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	129003	USD
CY2021Q2	us-gaap	Assets Assets	14025775	USD
CY2020Q3	us-gaap	Assets Assets	4682147	USD
CY2021Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	399599	USD
CY2020Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	487810	USD
CY2021Q2	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	5347	USD
CY2020Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	5687	USD
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	585776	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	401178	USD
CY2021Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	440239	USD
CY2020Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	591600	USD
CY2021Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	5006497	USD
CY2020Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3967578	USD
CY2021Q2	knwn	Simple Agreements For Future Equity Current SimpleAgreementsForFutureEquityCurrent	1125000	USD
CY2020Q3	knwn	Simple Agreements For Future Equity Current SimpleAgreementsForFutureEquityCurrent	785000	USD
CY2021Q2	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	226170	USD
CY2020Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	0	USD
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	31760	USD
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	108779	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	7820388	USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	6347632	USD
CY2021Q2	knwn	Notes Payable Ppp Loans NotesPayablePppLoans	205633	USD
CY2020Q3	knwn	Notes Payable Ppp Loans NotesPayablePppLoans	226170	USD
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23256	USD
CY2021Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	205633	USD
CY2020Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	249426	USD
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33719669	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24804874	shares
	us-gaap	Revenues Revenues	0	USD
	us-gaap	Revenues Revenues	121939	USD
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-73730093	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-55966281	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	5999754	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	-1914911	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14025775	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4682147	USD
CY2021Q2	us-gaap	Revenues Revenues	0	USD
CY2020Q2	us-gaap	Revenues Revenues	0	USD
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	33720	USD
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	24807	USD
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	79693322	USD
CY2020Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	54023758	USD
CY2020Q2	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
	us-gaap	Cost Of Revenue CostOfRevenue	69726	USD
CY2021Q2	us-gaap	Gross Profit GrossProfit	0	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	0	USD
	us-gaap	Gross Profit GrossProfit	0	USD
	us-gaap	Gross Profit GrossProfit	52213	USD
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	868584	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	375243	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3094123	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1313546	USD
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	994221	USD
CY2020Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	634169	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4934085	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3177661	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1862805	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1009412	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8028208	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4438994	USD
CY2021Q2	us-gaap	Interest Expense InterestExpense	5228058	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	1188874	USD
	us-gaap	Interest Expense InterestExpense	9735604	USD
	us-gaap	Interest Expense InterestExpense	4170038	USD
CY2021Q2	us-gaap	Other Income OtherIncome	0	USD
CY2020Q2	us-gaap	Other Income OtherIncome	0	USD
	us-gaap	Other Income OtherIncome	0	USD
	us-gaap	Other Income OtherIncome	65220	USD
CY2021Q2	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	0	USD
CY2020Q2	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	-706800	USD
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	0	USD
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	-706800	USD
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5228058	USD
CY2020Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1895674	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9735604	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4811618	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-7090863	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2905086	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-17763812	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-9250612	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20842782	shares
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-7090863	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-2905086	USD
	us-gaap	Net Income Loss NetIncomeLoss	-17763812	USD
	us-gaap	Net Income Loss NetIncomeLoss	-9250612	USD
CY2021Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.23
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.12
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.64
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.44
CY2021Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	31052229	shares
CY2020Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	23715823	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	27651679	shares
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	-3297290	USD
CY2019Q4	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	399897	USD
CY2019Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
CY2019Q4	knwn	Beneficial Conversion Feature BeneficialConversionFeature	330082	USD
CY2019Q4	knwn	Issuance Of Warrants To Debt Holders IssuanceOfWarrantsToDebtHolders	168270	USD
CY2019Q4	knwn	Adjustments To Additional Paid In Capital Warrant Issued For Services Related To Debt Offering AdjustmentsToAdditionalPaidInCapitalWarrantIssuedForServicesRelatedToDebtOffering	160427	USD
CY2019Q4	knwn	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	0	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-3015013	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-5253627	USD
CY2020Q1	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	165829	USD
CY2020Q1	knwn	Conversion Of Debt Offering And Accrued Interest Note7 Amount ConversionOfDebtOfferingAndAccruedInterestNote7Amount	4114800	USD
CY2020Q1	knwn	Beneficial Conversion Feature Note7 BeneficialConversionFeatureNote7	105535	USD
CY2020Q1	knwn	Issuance Of Warrants To Debt Holders Note7 IssuanceOfWarrantsToDebtHoldersNote7	21214	USD
CY2020Q1	knwn	Issuance Of Warrants For Services Related To Debt Offering Note7 IssuanceOfWarrantsForServicesRelatedToDebtOfferingNote7	9542	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1026000	USD
CY2020Q1	knwn	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	0	USD
CY2020Q2	knwn	Conversion Of Debt Offering And Accrued Interest Note10 Amount ConversionOfDebtOfferingAndAccruedInterestNote10Amount	472195	USD
CY2020Q2	knwn	Beneficial Conversion Feature Note10 BeneficialConversionFeatureNote10	3330457	USD
CY2020Q2	knwn	Issuance Of Warrants To Debt Holders Note10 IssuanceOfWarrantsToDebtHoldersNote10	1594043	USD
CY2020Q2	knwn	Issuance Of Warrants For Services Related To Debt Offering Note10 IssuanceOfWarrantsForServicesRelatedToDebtOfferingNote10	856370	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	19000	USD
CY2020Q2	knwn	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	55000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-2905086	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	416503	USD
CY2020Q4	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	175442	USD
CY2020Q4	knwn	Conversion Of Debt Offering And Accrued Interest Note7 Amount ConversionOfDebtOfferingAndAccruedInterestNote7Amount	561600	USD
CY2020Q4	knwn	Adjustments To Additional Paid In Capital Warrant Issued For Services To Related Party AdjustmentsToAdditionalPaidInCapitalWarrantIssuedForServicesToRelatedParty	1811691	USD
CY2020Q4	knwn	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	4688	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-5299331	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-4660822	USD
CY2021Q1	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	127407	USD
CY2021Q1	knwn	Conversion Of Debt Offering And Accrued Interest Note7 Amount ConversionOfDebtOfferingAndAccruedInterestNote7Amount	210606	USD
CY2021Q1	knwn	Beneficial Conversion Feature Note7 BeneficialConversionFeatureNote7	9769683	USD
CY2021Q1	knwn	Issuance Of Warrants To Debt Holders Note7 IssuanceOfWarrantsToDebtHoldersNote7	4439317	USD
CY2021Q1	knwn	Issuance Of Warrants For Services Related To Debt Offering Note7 IssuanceOfWarrantsForServicesRelatedToDebtOfferingNote7	1667281	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	202820	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4298179	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1900836	USD
CY2021Q1	knwn	Adjustments To Additional Paid In Capital Warrant Issued For Services To Related Party AdjustmentsToAdditionalPaidInCapitalWarrantIssuedForServicesToRelatedParty	382566	USD
CY2021Q1	knwn	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	648516	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-5373618	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	7413756	USD
CY2021Q2	knwn	Stock Compensation Expense Employee Options StockCompensationExpenseEmployeeOptions	267665	USD
CY2021Q2	knwn	Conversion Of Debt Offering And Accrued Interest Note7 Amount ConversionOfDebtOfferingAndAccruedInterestNote7Amount	5325853	USD
CY2021Q2	knwn	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	60000	USD
CY2021Q2	knwn	Issuance Of Common Stock For Stock Option Exercises Amount IssuanceOfCommonStockForStockOptionExercisesAmount	23344	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-7090863	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	5999754	USD
	us-gaap	Net Income Loss NetIncomeLoss	-17763812	USD
	us-gaap	Net Income Loss NetIncomeLoss	-9250612	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	166094	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	164078	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	202820	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1045000	USD
	knwn	Stock Based Compensation Warrants StockBasedCompensationWarrants	2194257	USD
	knwn	Stock Based Compensation Warrants StockBasedCompensationWarrants	0	USD
	knwn	Stock Based Compensation Stock Option Grants StockBasedCompensationStockOptionGrants	570514	USD
	knwn	Stock Based Compensation Stock Option Grants StockBasedCompensationStockOptionGrants	701470	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	9071592	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	3874018	USD
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1853	USD
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	778	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	4663	USD
	us-gaap	Nondebtor Reorganization Items Net Gain Loss On Settlement Of Other Claims1 NondebtorReorganizationItemsNetGainLossOnSettlementOfOtherClaims1	0	USD
	us-gaap	Nondebtor Reorganization Items Net Gain Loss On Settlement Of Other Claims1 NondebtorReorganizationItemsNetGainLossOnSettlementOfOtherClaims1	706800	USD
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	0	USD
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	63049	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	0	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	6435	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7103	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	11413	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-11414	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	404469	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	24073	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5144506	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2666115	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	47553	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13055	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-47553	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13055	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	14209000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	5639500	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	727117	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	479965	USD
	knwn	Proceeds From Simple Agreements For Future Equity ProceedsFromSimpleAgreementsForFutureEquity	340000	USD
	knwn	Proceeds From Simple Agreements For Future Equity ProceedsFromSimpleAgreementsForFutureEquity	0	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	205633	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	226170	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	23344	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	knwn	Proceeds From Issuance Of Common Stock For Warrant Exercise ProceedsFromIssuanceOfCommonStockForWarrantExercise	713203	USD
	knwn	Proceeds From Issuance Of Common Stock For Warrant Exercise ProceedsFromIssuanceOfCommonStockForWarrantExercise	55000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14764063	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5440705	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	9572004	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2761535	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13870183	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4662371	USD
	knwn	Cashless Stock Options Exercise CashlessStockOptionsExercise	0	USD
	us-gaap	Interest Paid Net InterestPaidNet	0	USD
	us-gaap	Interest Paid Net InterestPaidNet	0	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1928	USD
	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	9769683	USD
	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	3766074	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	4439317	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1783527	USD
	knwn	Adjustments To Additional Paid In Capital Warrant Issued For Services Related To Debt Offering AdjustmentsToAdditionalPaidInCapitalWarrantIssuedForServicesRelatedToDebtOffering	1667281	USD
	knwn	Adjustments To Additional Paid In Capital Warrant Issued For Services Related To Debt Offering AdjustmentsToAdditionalPaidInCapitalWarrantIssuedForServicesRelatedToDebtOffering	1026339	USD
	knwn	Cashless Exercise Of Warrant CashlessExerciseOfWarrant	493601	USD
	knwn	Cashless Exercise Of Warrant CashlessExerciseOfWarrant	57490	USD
	knwn	Cashless Stock Options Exercise CashlessStockOptionsExercise	18298	USD
	knwn	Conversion Of Debt Offering ConversionOfDebtOffering	5638275	USD
	knwn	Conversion Of Debt Offering ConversionOfDebtOffering	4235436	USD
	knwn	Conversion Of Accrued Interest ConversionOfAccruedInterest	460185	USD
	knwn	Conversion Of Accrued Interest ConversionOfAccruedInterest	351089	USD
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q2	us-gaap	Financing Receivable Deferred Income FinancingReceivableDeferredIncome	250000	USD
CY2020Q2	knwn	Royalty Payment Percentage On Gross Sales RoyaltyPaymentPercentageOnGrossSales	0.05	pure
CY2020Q2	us-gaap	Royalty Expense RoyaltyExpense	5000	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-73730093	USD
CY2021Q1	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	14209000	USD
CY2021Q1	knwn	Warrants In Private Placement To Accredited Investors WarrantsInPrivatePlacementToAccreditedInvestors	3552250	shares
CY2021Q1	us-gaap	Common Stock Convertible Conversion Price Increase CommonStockConvertibleConversionPriceIncrease	2.00
CY2021Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	14209000	USD
CY2021Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.08	pure
CY2021Q2	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	250000	USD
CY2021Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	13620183	USD
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Use of Estimates</strong> – The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3094123	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2033726	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1257872	USD
	us-gaap	Advertising Expense AdvertisingExpense	240000	USD
	us-gaap	Advertising Expense AdvertisingExpense	31000	USD
CY2021Q2	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	13619644	USD
CY2020Q2	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	4252959	USD
	us-gaap	Derivatives Methods Of Accounting Hedge Effectiveness DerivativesMethodsOfAccountingHedgeEffectiveness	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Derivative Financial Instruments –</strong>Pursuant to ASC 815 “Derivatives and Hedging”, the Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. The Company then determines if embedded derivative must bifurcated and separately accounted for. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company determined that the conversion features for purposes of bifurcation within its currently outstanding convertible notes payable were immaterial and there was no derivative liability to be recorded as of June 30, 2021 and September 30, 2020.</p>
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33719669	shares
	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	16124764	shares
CY2021Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	16464066	shares
	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	14659764	shares
CY2020Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	7894566	shares
CY2021Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	402827	USD
CY2020Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	355272	USD
CY2021Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3612	USD
CY2020Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3612	USD
CY2021Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	26854	USD
CY2020Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	26855	USD
CY2021Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	322049	USD
CY2020Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	257068	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	111244	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	128671	USD
CY2021Q2	us-gaap	Depreciation Depreciation	64980	USD
CY2020Q2	us-gaap	Depreciation Depreciation	51005	USD
CY2021Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	23169587	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y7M6D
CY2021Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	0.960
CY2021Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	23169587	shares
CY2021Q2	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	0.960
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	101114	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	129999	USD
CY2018Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	250000	USD
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	132000	USD
	us-gaap	Lease Cost LeaseCost	102741	USD
	us-gaap	Lease Cost LeaseCost	135828	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	104595	USD
	knwn	Finance Leases Weighted Average Remaining Lease Term FinanceLeasesWeightedAverageRemainingLeaseTerm	P11Y
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.07	pure
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	33983	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2223	USD
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	31760	USD
CY2021Q2	knwn	Convertible Notes Conversions ConvertibleNotesConversions	-9881990	USD
CY2020Q3	knwn	Convertible Notes Conversions ConvertibleNotesConversions	-4242490	USD
CY2021Q2	knwn	Debt Discount Beneficial Conversion Feature DebtDiscountBeneficialConversionFeature	-6770833	USD
CY2020Q3	knwn	Debt Discount Beneficial Conversion Feature DebtDiscountBeneficialConversionFeature	-2127894	USD
CY2021Q2	knwn	Debt Discount Warrants DebtDiscountWarrants	-3076542	USD
CY2020Q3	knwn	Debt Discount Warrants DebtDiscountWarrants	-1025512	USD
CY2021Q2	knwn	Debt Discount Warrants Issued For Services DebtDiscountWarrantsIssuedForServices	-1660194	USD
CY2020Q3	knwn	Debt Discount Warrants Issued For Services DebtDiscountWarrantsIssuedForServices	-823582	USD
CY2021Q2	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	5006497	USD
CY2020Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	3967578	USD
CY2021Q2	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	105000000	shares
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33719669	shares
CY2021Q2	knwn	Options To Purchase Common Stock Share OptionsToPurchaseCommonStockShare	14650120	shares
	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Unearned ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodUnearned	11775745	shares
CY2021Q2	knwn	Warrant Issued To Common Stock WarrantIssuedToCommonStock	23169587	shares
CY2021Q2	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	16124764	shares
CY2021Q2	knwn	Conversion Of Convertible Debentures ConversionOfConvertibleDebentures	16464066	USD
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	20016367	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.556
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	6237335	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.100
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2710260	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.561
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	373855	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.181
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	23169587	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.960
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	23169587	shares
	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Unearned ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodUnearned	11775745	shares
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	416055	USD
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	701470	USD
CY2021Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1062233	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y9M21D
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3706519	USD
CY2019	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrossGranted	7504850	USD
CY2019	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrossExercised	0	USD
CY2019	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options In Period Gross Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsInPeriodGrossForfeitures	2031000	USD
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	9180369	USD
CY2020	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrossGranted	3522400	USD
CY2020	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrossExercised	18298	USD
CY2020	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options In Period Gross Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsInPeriodGrossForfeitures	7103921	USD
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5580550	USD
	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrossGranted	16743590	USD
	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrossExercised	28031	USD
	knwn	Share Based Compensation Arrangement By Share Based Payment Award Options In Period Gross Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsInPeriodGrossForfeitures	396000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	32629376	shares
	knwn	Summarize Information About Particle Stock Option And Exercisabletabletextblock SummarizeInformationAboutParticleStockOptionAndExercisabletabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Range of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Prices</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Number </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Outstanding</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Weighted </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Average </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Remaining Life </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>In Years</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Weighted </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Average </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Exercise Price</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Number </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Exerciseable</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Weighted </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Average </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Exercise Price </strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Exerciseable</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td style="width:13%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.10</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:14%;vertical-align:bottom;text-align:right;">4,600,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:14%;vertical-align:bottom;text-align:right;">3.98</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:14%;vertical-align:bottom;text-align:right;">0.10</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:14%;vertical-align:bottom;text-align:right;">1,000,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:14%;vertical-align:bottom;text-align:right;">0.10</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.80</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">2,600,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">4.61</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.80</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">-</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">-</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">7,200,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">4.21</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.35</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="vertical-align:bottom;text-align:right;">1,000,000</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="vertical-align:bottom;text-align:right;">0.10</td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
	knwn	Segment Revenues SegmentRevenues	0	USD
	knwn	Segment Gross Profit SegmentGrossProfit	0	USD
CY2021Q2	knwn	Segment Net Income Loss SegmentNetIncomeLoss	-1863000	USD
CY2021Q2	knwn	Segment Assets SegmentAssets	14026000	USD
CY2021Q2	knwn	Segment Revenues SegmentRevenues	0	USD
CY2020Q2	knwn	Segment Gross Profit SegmentGrossProfit	0	USD
CY2020Q2	knwn	Segment Net Income Loss SegmentNetIncomeLoss	-1009000	USD
CY2020Q2	knwn	Segment Revenues SegmentRevenues	0	USD
	knwn	Segment Net Income Loss SegmentNetIncomeLoss	-8028000	USD
	knwn	Segment Revenues SegmentRevenues	122000	USD
	knwn	Segment Gross Profit SegmentGrossProfit	52000	USD
	knwn	Segment Net Income Loss SegmentNetIncomeLoss	-4439000	USD
CY2020Q2	knwn	Segment Assets SegmentAssets	5040000	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	12203424	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	6495251	USD

Files In Submission

Name	View Source	Status
0001654954-21-009080-index-headers.html	Edgar Link	pending
0001654954-21-009080-index.html	Edgar Link	pending
0001654954-21-009080.txt	Edgar Link	pending
0001654954-21-009080-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
knwn-20210630.xsd	Edgar Link	pending
knwn-20210630_cal.xml	Edgar Link	unprocessable
knwn-20210630_def.xml	Edgar Link	unprocessable
knwn-20210630_lab.xml	Edgar Link	unprocessable
knwn-20210630_pre.xml	Edgar Link	unprocessable
knwn_10q.htm	Edgar Link	pending
knwn_10qimg1.jpg	Edgar Link	pending
knwn_10q_htm.xml	Edgar Link	completed
knwn_ex311.htm	Edgar Link	pending
knwn_ex312.htm	Edgar Link	pending
knwn_ex321.htm	Edgar Link	pending
knwn_ex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KNW
KNOW LABS, INC. Stock $knw

2021 Q3 Form 10-Q Financial Statement

#000165495421009080 Filed on August 16, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KNW KNOW LABS, INC. Stock $knw

2021 Q3 Form 10-Q Financial Statement

#000165495421009080 Filed on August 16, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KNW
KNOW LABS, INC. Stock $knw